Calcium entry activated by store depletion in coronary endothelium is promoted by tyrosine phosphorylation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Sharma, Neeraj R ^a   Davis, Michael J ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

calcium ion release activated current; endothelial cells; fura 2; genistein; patch clamp; perforated patch; porcine coronary artery; substance P; tyrosine kinase

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CALCIUM ION; DAIDZEIN; FLUORESCEIN ISOTHIOCYANATE; GENISTEIN; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE INHIBITOR; SUBSTANCE P; TERT BUTYLHYDROQUINONE; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CIRCUMFLEX BRANCH; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SWINE; VASCULAR ENDOTHELIUM; VOLTAGE CLAMP;

EID: 0030041055     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.1.h267     Document Type: Article

References (30)

1. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
2. 2 entry in pancreatic acinar cells. J. Biol. Chem. 268: 10808-10812, 1993.
3. Bull, H. A., P. M. Brickell, and P. M. Dowd. src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEES. Lett. 351: 41-44, 1994.
4. Fincham, V., M. Frame, B. Haefner, M. Unlu, A. Wyke, and J. Wyke. Functions of the v-src protein tyrosine kinase. Cell Biol. Int. 18: 337-344, 1994.
5. Fleming, I., B. Fisslthaler, and R. Busse. Calcium signalling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen activated protein kinases (Abstract). FASEB J. 9:A872, 1995.
6. Franzius, D., M. Hoth, and R. Penner. Non-specific effects of calcium entry antagonists in mast cells. Pfluegers Arch. 428: 433-438, 1994.
7. Gazit, A., P. Yaish, C. Gilon, and A. Levitzki. Tyrphostins I: synthesis and biological activity of protein kinase inhibitors. J. Med. Chem. 32: 2344-2352, 1989.
8. Gericke, M., G. Droogmans, and B. Nilius. Thapsigargin discharges intracellular calcium stores and induces transmembrane currents in human endothelial cells. Pfluegers Arch. 422: 552-557, 1993.
9. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
10. Hamill, O. P., A. Marty, E. Neher, and F. J. Sigworth. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch. 391: 85-100, 1981.
11. Hoth, M., and R. Penner. Calcium release-activated calcium current in rat mast cells. J. Physiol. Lond. 465: 359-386, 1993.
12. Kawamoto, S., and H. Hidaka. 1-(5-isoquinoline sulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem. Biophys. Res. Commun. 125: 258-264, 1984.
13. Kruse, H. J., E. V. Negrescu, P. C. Weber, and W. Siess. Thrombin-induced Ca influx and protein tyrosine phosphorylation in endothelial cells is inhibited by herbimycin A. Biol. Biophy Res. Commun. 202: 1651-1656, 1994.
14. Lee, K.-M., K. Toscas, and M. L. Villereal. Inhibition of bradykinin-and thapsigargin-induced Ca entry by tyrosine kinase inhibitors. J. Biol. Chem. 268: 9945-9948, 1993.
15. 2+-translocase inhibitors thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone on cellular calcium fluxes. Biochem. J. 277: 553-556, 1991.
16. Long, C. J., and T. W. Stone. The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels 22: 205-208, 1985.
17. 2+ imaging in single living cells: theoretical and practical issues. Cell Calcium 11: 157-179, 1990.
18. 2+-releasing mechanisms revealed by manoalide and benzohydroquinone. Biochem. J. 279: 367-375, 1991.
19. + current by means of a phosphatase and a diffusible messenger. Nature Land. 364: 814-818, 1993.
20. 2+ entry revisited. Cell Calcium 11: 611-624, 1990.
21. Rae, J., K. Cooper, P. Gates, and M. Watsky. Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods 37: 15-26, 1991.
22. 2+ influx. Nature Lond. 364: 809-814, 1993.
23. Saito, R., S. Nonaka, H. Konishi, Y. Takano,Y. Shimohigashi, H. Matsumoto, M. Ohno, and H. Kamiya. Pharmacological properties of the tachykinin receptor subtype in the endothelial cell and vasodilation. Ann. NY. Acad. Sci. 632: 457-459, 1991.
24. Sergeant, P., R. W. Farndale, and S. O. Sage. ADP-and thapsigargin-evoked Ca entry and protein-tyrosine phosphoryla-tion are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J. Biol. Chem. 268: 18151-18156, 1993.
25. 2+-influx pathway. Biochem. J. 284: 521-530, 1992.
26. Sharma, N. R., and M. J. Davis. Mechanism of substance P-induced hyperpolarization of porcine coronary artery endothelial cells. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H156-H164, 1994.
27. Sharma, N. R., and M. J. Davis. Substance P-induced calcium entry in endothelial cells is secondary to depletion of intracellular stores. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H962-H973, 1995.
28. 2+ current. Am. J Physiol. 264 (Heart Circ. Physiol. 33): H1319-H1322, 1993
29. Wahl, M. I., T. O. Daniel, and G. Carpenter. Antiphosphotyrosine recovery of phospholipase C activity after EGF treatment of A431 cells. Science Wash. DC 241: 968-971, 1988.
30. Wijetunge, S., C. Aalkjaer, M. Schachter, and A. D. Hughes. Tyrosine kinase inhibitors block calcium currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623, 1992.